Skip to main content

Advertisement

Fig. 2 | EJNMMI Research

Fig. 2

From: [18F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer

Fig. 2

Representative [18F]FMISO PET/CT images (a, b, c) and HIF-1α immunohistochemical images (d, e) of pancreatic cancer. A color bar from 0 to 3 indicates standardize uptake value (SUV) of fused [18F]FMISO images. The first case with increased [18F]FMISO uptake on the primary tumor (a, arrows) was finally decided as inoperable. The second case with moderate [18F]FMISO uptake (b, arrows) received operation, and the immunohistochemistry shows strong HIF-1α expression (d). The third case with low [18F]FMISO uptake (c, arrows) also received operation, and the immunohistochemistry shows no apparent HIF-1α expression (e)

Back to article page